These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 38022117)

  • 1. The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications.
    Jain A; Madkan S; Patil P
    Cureus; 2023 Oct; 15(10):e47861. PubMed ID: 38022117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
    Spielman LJ; Gibson DL; Klegeris A
    Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The connection between gut microbiota and its metabolites with neurodegenerative diseases in humans.
    Fabi JP
    Metab Brain Dis; 2024 Jun; 39(5):967-984. PubMed ID: 38848023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.
    Ning J; Huang SY; Chen SD; Zhang YR; Huang YY; Yu JT
    J Alzheimers Dis; 2022; 87(1):211-222. PubMed ID: 35275534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.
    Heravi FS; Naseri K; Hu H
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbiosis of Gut Microbiota from the Perspective of the Gut-Brain Axis: Role in the Provocation of Neurological Disorders.
    Kandpal M; Indari O; Baral B; Jakhmola S; Tiwari D; Bhandari V; Pandey RK; Bala K; Sonawane A; Jha HC
    Metabolites; 2022 Nov; 12(11):. PubMed ID: 36355147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
    Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
    Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics.
    Banerjee A; Pradhan LK; Sahoo PK; Jena KK; Chauhan NR; Chauhan S; Das SK
    Arch Microbiol; 2021 Aug; 203(6):2895-2910. PubMed ID: 33763767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
    Zheng Y; Bonfili L; Wei T; Eleuteri AM
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence.
    Liu X; Liu Y; Liu J; Zhang H; Shan C; Guo Y; Gong X; Cui M; Li X; Tang M
    Neural Regen Res; 2024 Apr; 19(4):833-845. PubMed ID: 37843219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.
    Fang X
    Int J Neurosci; 2016 Sep; 126(9):771-6. PubMed ID: 26381230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives.
    Noor Eddin A; Alfuwais M; Noor Eddin R; Alkattan K; Yaqinuddin A
    Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders.
    Padhi P; Worth C; Zenitsky G; Jin H; Sambamurti K; Anantharam V; Kanthasamy A; Kanthasamy AG
    Front Neurosci; 2022; 16():836605. PubMed ID: 35281490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases.
    Gubert C; Kong G; Renoir T; Hannan AJ
    Neurobiol Dis; 2020 Feb; 134():104621. PubMed ID: 31628992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the preclinical and clinical studies on the role of the gut microbiome in aging and neurodegenerative diseases and its modulation.
    Hashim HM; Makpol S
    Front Cell Neurosci; 2022; 16():1007166. PubMed ID: 36406749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of gut microbiota on neurodegenerative diseases.
    Khatoon S; Kalam N; Rashid S; Bano G
    Front Aging Neurosci; 2023; 15():1145241. PubMed ID: 37323141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Microbiome in Brain Development and Neurodegenerative Diseases.
    Nandwana V; Nandwana NK; Das Y; Saito M; Panda T; Das S; Almaguel F; Hosmane NS; Das BC
    Molecules; 2022 May; 27(11):. PubMed ID: 35684340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.
    Rutsch A; Kantsjö JB; Ronchi F
    Front Immunol; 2020; 11():604179. PubMed ID: 33362788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders.
    Chandra S; Alam MT; Dey J; Sasidharan BCP; Ray U; Srivastava AK; Gandhi S; Tripathi PP
    Curr Top Med Chem; 2020; 20(13):1142-1153. PubMed ID: 32282304
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.